Our AI agents propose a classification for each entity, and your team decides.
Example data
Pharma manufacturers and medicinal product research can be particularly important entities. Chemicals manufacturers and importers that must register under REACH are important entities at most, unless they operate a critical installation. From 50 staff, or over €10 million in both turnover and balance sheet, both register with the BSI.
The agents map the duties to the controls you already run and draft the reporting process.
Check each group entity on its own.
The BSI Act does not apply on these answers.
You register with the BSI, put the ten minimum measures in place and report significant incidents within 24 hours, 72 hours and one month. Fines up to €7 million, or up to 1.4% of worldwide turnover above €500 million turnover.
The same duties apply as for important entities, with higher fines. Up to €10 million, or up to 2% of worldwide turnover above €500 million turnover.
As the operator of a critical installation, you also run attack detection systems and prove your measures every three years.
Health and genetic data is specially protected. Large-scale processing needs a data protection impact assessment.
Whether an installation is critical currently depends on the BSI-Kritisverordnung. Negligible business activities can be left out of the classification. This helper is not legal advice.
Tick what you can prove today. Your result stays in your browser.
The foundation is still missing
Book a demoProgram in place, operations not yet
Book a demoReady for supervisory questions
Book a demoPharma and chemicals have the same duties. The classification differs. Check NIS2 applicability per entity
Manufacturing pharmaceutical products and researching medicinal products belong to the health sector. From 250 staff, or over €50 million turnover and over €43 million balance sheet, an entity is particularly important.
The act covers manufacturers and importers of chemical substances and mixtures that must register under REACH. They are important entities at most, unless they run a critical installation.
Significant incidents go to the joint reporting office of BSI and BBK.
It implements and oversees the measures and attends training regularly.
Our AI agents propose a classification for each entity and map the requirements to your controls. They also draft the reporting process.
GetTeddy checks each entity by activity, size and critical installations. The reasoning is ready for Legal.
GetTeddy collects what the BSI asks for, such as contact data, public IP ranges and sector. You check the data and submit it yourself.
GetTeddy maps the ten minimum measures to the controls you run for ISO 27001. The Contract Agent checks contracts with contract manufacturers and service providers for security requirements.
The Policy Agent drafts the staged reporting process with roles, criteria and templates. It links it with the data breach report.
The Evidence Agent links evidence from connected tools to each requirement. The Questionnaire Agent answers security questionnaires from current evidence. Gap audits run every week.
IT, production and management ask the same questions in their own words. GetTeddy answers from your program.
| Typical | With GetTeddy | |
|---|---|---|
| Applicability | Workshops per entity | Suggestion with reasons, confirmed by your team |
| Measures | Separate spreadsheets per site | Mapped to the same controls |
| Reporting | Deadlines looked up during the incident | Process and templates with named roles |
| Data breaches | NIS2 report and data breach handled separately | Reporting process linked with the data breach report |
Chemicals are in Annex 2 of the BSI Act. Annex 2 entities are important entities from 50 staff, or over €10 million in both turnover and balance sheet. They only become particularly important as the operator of a critical installation. Fines reach up to €7 million, or up to 1.4% of worldwide turnover above €500 million turnover.
Manufacturers and importers of chemical substances and mixtures of NACE division 20 that must register under REACH. They are in Annex 2 of the BSI Act. From 50 staff, or over €10 million in both turnover and balance sheet, they are important entities and register with the BSI within three months.
Yes. Companies that research and develop medicinal products are in Annex 1 of the BSI Act, like pharmaceutical manufacturers. From 50 staff, or over €10 million in both turnover and balance sheet, they are important entities. From 250 staff, or over €50 million turnover and over €43 million balance sheet, they are particularly important.
Under the BSI-Kritisverordnung, a production site for prescription medicines counts as critical from 4.65 million packs placed on the market a year. Its operator is always a particularly important entity under the BSI Act. Critical installations also need attack detection systems and prove their measures every three years.
Read next NIS2 · ISO 27001 · ISO 42001 · Healthcare · Medical device manufacturers
We show you how it works on your own group structure.